China SXT Pharmaceuticals, Inc. (SXTC) stock

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30

$3.00+0.27 (+9.89%)

Close on Nov 13, 2026Market cap $2.87MP/E –Yield –

China SXT Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

China SXT Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in China SXT Pharmaceuticals's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-80 reverse split on Aug 10, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing